Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2018 3
2019 4
2020 4
2021 5
2022 15
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Psychotropic Drugs and Liver Toxicity.
Gómez-Lumbreras A, Marcos-Fosch C, Aguilera C. Gómez-Lumbreras A, et al. Am J Ther. 2018 Sep/Oct;25(5):e601-e602. doi: 10.1097/MJT.0000000000000615. Am J Ther. 2018. PMID: 30188878 No abstract available.
How many manuscripts should I peer review per year?
Fernandez-Llimos F, Salgado TM, Tonin FS; Pharmacy Practice 2019 peer reviewers. Fernandez-Llimos F, et al. Pharm Pract (Granada). 2020 Jan-Mar;18(1):1804. doi: 10.18549/PharmPract.2020.1.1804. Epub 2020 Jan 14. Pharm Pract (Granada). 2020. PMID: 32161628 Free PMC article.
Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support.
Zhang T, Gephart SM, Subbian V, Boyce RD, Villa-Zapata L, Tan MS, Horn J, Gomez-Lumbreras A, Romero AV, Malone DC. Zhang T, et al. Among authors: gomez lumbreras a. Appl Clin Inform. 2023 Aug;14(4):779-788. doi: 10.1055/s-0043-1772686. Epub 2023 Oct 4. Appl Clin Inform. 2023. PMID: 37793617
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".
Malone DC, Villa-Zapata L, Gómez-Lumbreras A, Horn J, Tan MS, Boyce RD. Malone DC, et al. Among authors: gomez lumbreras a. Drug Saf. 2022 Dec;45(12):1553-1555. doi: 10.1007/s40264-022-01239-3. Epub 2022 Oct 12. Drug Saf. 2022. PMID: 36223037 No abstract available.
Linaclotide utilization and potential for off-label use and misuse in three European countries.
Cid-Ruzafa J, Lacy BE, Schultze A, Duong M, Lu Y, Raluy-Callado M, Donaldson R, Weissman D, Gómez-Lumbreras A, Ouchi D, Giner-Soriano M, Morros R, Ukah A, Pohl D. Cid-Ruzafa J, et al. Among authors: gomez lumbreras a. Therap Adv Gastroenterol. 2022 Jun 11;15:17562848221100946. doi: 10.1177/17562848221100946. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35706826 Free PMC article.
44 results